基因治疗和基因编辑策略在遗传性血液疾病中
Xuemei Song1, JinLei Liu1, Tangcong Chen1
1Institute of Blood Diseases, Department of Hematology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, School of Medicine of University of Electronic Science and Technology of China, Chengdu, Sichuan 610000, China.
Journal of genetics and genomics = Yi chuan xue bao
|July 10, 2024
概括
基因疗法,包括基于CRISPR的工具,如基因和原始编辑,对遗传性血液疾病有很大的希望. 已批准的疗法针对状细胞病和血病等疾病的BCL11A.
科学领域:
- 血液学 血液学 血液学
- 遗传学 遗传学 是一个
- 生物技术是生物技术.
背景情况:
- 基因疗法为治疗遗传性血液疾病提供了显著的潜力,包括血友病,状细胞病和血病.
- 基因调节网络的进步已经确定了新的治疗点,特别是对于β-hemoglobinopathies.
- BCL11A已经成为β-hemoglobinopathies的关键治疗标.
研究的目的:
- 审查遗传性血液疾病的基因疗法的当前景观.
- 评估当前实践中使用的潜在基因标和基因编辑工具.
- 为开发更安全,更有效的基因疗法提供见解.
主要方法:
- 对遗传性血液疾病的临床研究和基因疗法产品的审查.
- 评估BCL11A作为治疗点.
- 评估基因编辑技术,如基因编辑和原始编辑.
主要成果:
- 针对BCL11A的基因疗法产品Casgevy在2023年获得了英国和美国的批准,用于治疗β-hemoglobinopathies.
- 基于CRISPR的技术,包括基和原始编辑,可以在造血干细胞中精确地进行单基修改.
- 这些技术为遗传性血液疾病的ex vivo和in vivo基因校正提供了潜力.
结论:
- 基因疗法,特别是基因编辑方面的进步,为治疗更广泛的遗传性血液疾病提供了有希望的未来.
- 向BCL11A代表了在管理β-hemoglobinopathies方面迈出的重要一步.
- 对基因编辑工具和目标的持续研究将推动开发更有效,更安全的治疗策略.
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
CRISPR
50.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
50.4K
What is Genetic Engineering?
74.0K
Overview
74.0K
In-vitro Mutagenesis
13.9K
To learn more about the function of a gene, researchers can observe what happens when the gene is inactivated or “knocked out,” by creating genetically engineered knockout animals. Knockout mice have been particularly useful as models for human diseases such as cancer, Parkinson’s disease, and diabetes.
13.9K
Bone Marrow Sampling and Transplants
323
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
323
RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K


